eem for oral lichen planus patients.
Phase 3
Completed
- Conditions
- Health Condition 1: D899- Disorder involving the immune mechanism, unspecified
- Registration Number
- CTRI/2019/01/017246
- Lead Sponsor
- Dr Ashita Kalaskar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Symptomatic Patients with any clinical types and manifestations of
OLP and those confirmed histopathologically will be included in the
study.
2.Patients who have discontinued previous treatment for OLP for last
six months.
Exclusion Criteria
1.Patients younger than 16 years old.
2.Patients with skin lesions.
3.Patients with non symptomatic OLP lesions
4.Patients with lesions showing malignant or dysplasic changes.
5.Patients undergoing any other treatment for oral lichen planus.
Pregnant and nursing woman.
Patients having systemic problems or under any medications for the
same.
Patients having habit of chewing tobacco and betelnut or smoking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Burning sensation will be evaluated by visual analog scale. <br/ ><br>The severity of lesions on each side will be <br/ ><br>evaluated by Thongprasom criteria.Timepoint: 1st day, 3rd day, 7th day, 2nd week, 3rd week, 4th week, 2nd month and 3rd month
- Secondary Outcome Measures
Name Time Method Acceptability of neem mouthwash. <br/ ><br>Total duration required to decrease the <br/ ><br>symptoms. <br/ ><br>Recurrence of the lesions in two months <br/ ><br>follow-up. Clinical improvement.Adverse effects if any.Timepoint: 1st day, 3rd day, 7th day, 2nd <br/ ><br>week, 3rd week, 4th week, 2nd month, 3rd <br/ ><br>month.